EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Whole-genome doubling drives immune evasion by silencing antigen presentation

Pierre Foidart, Zheqi Li, Xinran Cai, Marco Seehawer, Daniel D Brown, Amatullah Tawawalla, Pilar Baldominos, Salma Parvin, Jun Nishida, Ernesto Rojas-Jimenez, Triet M Bui, Benedetto Diciaccio und 24 weitere

Cancer Cell · 2026-07 · 44 (7) · 1418-1436.e12

DOI: 10.1016/j.ccell.2026.04.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2026-07. Verfasst von Pierre Foidart und 35 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA…. Hauptthemen laut MEDLINE: Antigen Presentation, Tumor Escape, Genome, Immune Evasion. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, Charles A King Trust, Wallonie-Bruxelles International.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Whole-genome doubling (WGD) is a common yet poorly understood event associated with poor clinical outcomes. Here, we characterize mechanisms by which WGD drives tumor evolution, utilizing mouse mammary tumor models of WGD established through cell fusion. We find that WGD increases transcriptomic and epigenetic heterogeneity and identify the YM155 BIRC5 inhibitor as a compound specifically suppressing WGD+ tumors. WGD triggers immune evasion by escaping CD8+ T cell responses, rendering WGD+ tumors more sensitive to anti-PD-L1. Through single-cell profiling, we discover that WGD+ cancer cells exhibit reduced antigen presentation and response to IFNγ, attributed to the epigenetic silencing of MHCI transcriptional regulators via elevated histone H3 lysine 27 trimethylation. Further investigations reveal decreased KDM6 activity and increased succinate levels in WGD+ tumors. PRC2 inhibition preferentially suppresses WGD+ tumor growth, enhances antigen presentation, and CD8+ T cell infiltration. Our results underscore metabolic and epigenetic alterations as critical drivers of WGD-associated immune escape.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigen PresentationTumor EscapeGenomeImmune EvasionAnimalsFemaleMiceCD8-Positive T-LymphocytesHumansEpigenesis, GeneticCell Line, TumorSurvivinGene Silencing

Stichwörter der Autor:innen

antigen presentationbreast cancerepigenetic silencingimmune escapewhole genome doubling

Substanzen

Survivin

Autor:innen und Institutionen

  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, M…
  • Institute for Precision Medicine, University of Pittsburgh, Pittsburgh, PA 15260, USA.
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA.
  • Women's Cancer Research Center, UPMC Hillman Cancer Center, Magee-Women's Research Institute, Pittsburgh, PA 15260, USA; Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA 15260, U…
  • Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

Förderung

  • NCI NIH HHS
  • Charles A King Trust
  • Wallonie-Bruxelles International
  • National Cancer Institute
  • Canadian Institutes of Health Research
  • Medical Center, University of Pittsburgh
  • Dana-Farber Cancer Institute
  • Harvard Medical School Ludwig Center

Zitieren

APA

Foidart, P., Li, Z., Cai, X., Seehawer, M., Brown, D. D., Tawawalla, A., Baldominos, P., Parvin, S., Nishida, J., Rojas-Jimenez, E., Bui, T. M., Diciaccio, B., Kumar, R., Schlegel, B. T., Goyette, M. A., Scales, T., Yan, P., Qiu, X., Li, R., …, & Polyak, K. (2026). Whole-genome doubling drives immune evasion by silencing antigen presentation. Cancer Cell, 44(7), 1418-1436.e12. https://doi.org/10.1016/j.ccell.2026.04.007

Vancouver

Foidart P, Li Z, Cai X, Seehawer M, Brown DD, Tawawalla A, et al. Whole-genome doubling drives immune evasion by silencing antigen presentation. Cancer Cell. 2026;44(7):1418-1436.e12. doi:10.1016/j.ccell.2026.04.007

BibTeX
@article{Foidart2026,
  author = {Foidart, Pierre and Li, Zheqi and Cai, Xinran and Seehawer, Marco and Brown, Daniel D and Tawawalla, Amatullah and Baldominos, Pilar and Parvin, Salma and Nishida, Jun and Rojas-Jimenez, Ernesto and Bui, Triet M and Diciaccio, Benedetto and Kumar, Rahul and Schlegel, Brent T and Goyette, Marie-Anne and Scales, TashJae and Yan, Pengze and Qiu, Xintao and Li, Rong and Jiang, Yijia and Xie, Yingtian and Aarabi, Mahmoud and Huang, Xiao-Yun and Stevens, Laura E and Cejas, Paloma and Mangiante, Lise and Sotomayor Vivas, Cristina Irene and Houlahan, Kathleen E and Curtis, Christina and Oesterreich, Steffi and Harris, Isaac S and Letai, Anthony G and Lee, Adrian V and Long, Henry W and Agudo, Judith and Polyak, Kornelia},
  title = {Whole-genome doubling drives immune evasion by silencing antigen presentation},
  journal = {Cancer Cell},
  year = {2026},
  volume = {44},
  number = {7},
  pages = {1418--1436.e12},
  doi = {10.1016/j.ccell.2026.04.007}
}
Kostenlos starten →